(Q51053523)

27 March 2018

title

Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children. (English)

1 reference

27 March 2018

1 reference

1 reference

Guo-Lin Bian

1

1 reference

27 March 2018

Rui Ma

2

1 reference

27 March 2018

Hong-Jun Dong

3

1 reference

27 March 2018

Hong-Xia Ni

4

1 reference

27 March 2018

Feng-Jiao Hu

5

1 reference

27 March 2018

Yao-Rong Chen

6

1 reference

27 March 2018

Jia-Qun Chen

7

1 reference

27 March 2018

Shao-Ying Zhou

8

1 reference

27 March 2018

Yong-Xin Lin

9

1 reference

27 March 2018

Guo-Zhang Xu

10

1 reference

27 March 2018

language of work or name

English

0 references

publication date

14 May 2010

1 reference

27 March 2018

published in

Vaccine

1 reference

27 March 2018

volume

28

1 reference

27 March 2018

issue

30

1 reference

27 March 2018

page(s)

4798-4801

1 reference

27 March 2018

Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Effect of Hepatitis A Vaccination Programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Hepatitis A booster vaccination: is there a need?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Prevention of hepatitis A by Havrix: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Comparative immunogenicity and tolerance of Vaqta and Havrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Properties of IgG subclasses to human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Functional diversity of helper T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.096

10.1016/J.VACCINE.2010.04.096

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018